| Wade Erickson, MD | |
|
3066 E Meridian Park Loop, Wasilla, AK 99654-7299 | |
| (907) 357-9593 | |
| Not Available |
| Full Name | Wade Erickson |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 26 Years |
| Location | 3066 E Meridian Park Loop, Wasilla, Alaska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245278183 | NPI | - | NPPES |
| MD45932 | Medicaid | AK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 4593 (Alaska) | Primary |
| 183500000X | Pharmacist | 4593 (Alaska) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mat-su Regional Medical Center | Palmer, AK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Medical Network Of Alaska Llc | 3072618859 | 61 |
News Archive
The researchers reviewed the 92 patients requiring assessment for human bite wounds by the plastic surgery service at St James Hospital Dublin, Ireland, between January 2003 and December 2005. Eight five of them (92%) were men and the 92 patients had a total of 96 bites.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
A report just released by Cogent Research, in partnership with CAHG, reveals that Americans are more concerned than ever about the privacy of their genetic information. Furthermore, this concern is increasingly inhibiting the likelihood that they will consider having a molecular diagnostic test. These and other findings are explored in more detail in the 5th edition of the Cogent Genomics, Attitudes & Trends study (CGAT 2010).
› Verified 2 days ago
| Entity Name | Mat Su Valley Medical Center Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912950148 PECOS PAC ID: 5698686475 Enrollment ID: O20040123000583 |
News Archive
The researchers reviewed the 92 patients requiring assessment for human bite wounds by the plastic surgery service at St James Hospital Dublin, Ireland, between January 2003 and December 2005. Eight five of them (92%) were men and the 92 patients had a total of 96 bites.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
A report just released by Cogent Research, in partnership with CAHG, reveals that Americans are more concerned than ever about the privacy of their genetic information. Furthermore, this concern is increasingly inhibiting the likelihood that they will consider having a molecular diagnostic test. These and other findings are explored in more detail in the 5th edition of the Cogent Genomics, Attitudes & Trends study (CGAT 2010).
› Verified 2 days ago
| Entity Name | Medical Network Of Alaska Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538414834 PECOS PAC ID: 3072618859 Enrollment ID: O20070424000329 |
News Archive
The researchers reviewed the 92 patients requiring assessment for human bite wounds by the plastic surgery service at St James Hospital Dublin, Ireland, between January 2003 and December 2005. Eight five of them (92%) were men and the 92 patients had a total of 96 bites.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
A report just released by Cogent Research, in partnership with CAHG, reveals that Americans are more concerned than ever about the privacy of their genetic information. Furthermore, this concern is increasingly inhibiting the likelihood that they will consider having a molecular diagnostic test. These and other findings are explored in more detail in the 5th edition of the Cogent Genomics, Attitudes & Trends study (CGAT 2010).
› Verified 2 days ago
| Entity Name | New Frontier Anesthesia, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255604948 PECOS PAC ID: 2567624257 Enrollment ID: O20120425000361 |
News Archive
The researchers reviewed the 92 patients requiring assessment for human bite wounds by the plastic surgery service at St James Hospital Dublin, Ireland, between January 2003 and December 2005. Eight five of them (92%) were men and the 92 patients had a total of 96 bites.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
A report just released by Cogent Research, in partnership with CAHG, reveals that Americans are more concerned than ever about the privacy of their genetic information. Furthermore, this concern is increasingly inhibiting the likelihood that they will consider having a molecular diagnostic test. These and other findings are explored in more detail in the 5th edition of the Cogent Genomics, Attitudes & Trends study (CGAT 2010).
› Verified 2 days ago
| Entity Name | Capstone Urgent Care Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538414834 PECOS PAC ID: 0941452551 Enrollment ID: O20121205000549 |
News Archive
The researchers reviewed the 92 patients requiring assessment for human bite wounds by the plastic surgery service at St James Hospital Dublin, Ireland, between January 2003 and December 2005. Eight five of them (92%) were men and the 92 patients had a total of 96 bites.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
A report just released by Cogent Research, in partnership with CAHG, reveals that Americans are more concerned than ever about the privacy of their genetic information. Furthermore, this concern is increasingly inhibiting the likelihood that they will consider having a molecular diagnostic test. These and other findings are explored in more detail in the 5th edition of the Cogent Genomics, Attitudes & Trends study (CGAT 2010).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wade Erickson, MD 3066 E Meridian Park Loop, Wasilla, AK 99654-7299 Ph: (907) 357-9593 | Wade Erickson, MD 3066 E Meridian Park Loop, Wasilla, AK 99654-7299 Ph: (907) 357-9593 |
News Archive
The researchers reviewed the 92 patients requiring assessment for human bite wounds by the plastic surgery service at St James Hospital Dublin, Ireland, between January 2003 and December 2005. Eight five of them (92%) were men and the 92 patients had a total of 96 bites.
Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.
A researcher in the Oregon Health & Science University Cancer Institute and Portland Veterans Affairs Medical Center has found a way to identify which men need a second prostate biopsy because they may be harboring life-threatening prostate cancer even though they were given a clean bill of health after their first biopsy.
A report just released by Cogent Research, in partnership with CAHG, reveals that Americans are more concerned than ever about the privacy of their genetic information. Furthermore, this concern is increasingly inhibiting the likelihood that they will consider having a molecular diagnostic test. These and other findings are explored in more detail in the 5th edition of the Cogent Genomics, Attitudes & Trends study (CGAT 2010).
› Verified 2 days ago
Dr. Robert Neubauer, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 Bogard Rd Ste 233, Wasilla, AK 99654 Phone: 907-352-2880 Fax: 907-352-2999 | |
Christopher James Sahlstrom, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 4961 E Mayflower Ln, Wasilla, AK 99654 Phone: 907-357-3496 | |
Nathan Neves George, NP Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 E Bogard Rd Ste 228, Wasilla, AK 99654 Phone: 907-376-8938 | |
Dr. Kristel Wyn Rush, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1363 W Spruce Ave, Wasilla, AK 99654 Phone: 907-376-2411 Fax: 907-352-3301 | |
Laurie Elizabeth Dahms, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1001 S Knik Goose Bay Rd, Wasilla, AK 99654 Phone: 907-631-7800 Fax: 907-631-7612 | |
Dr. Duane I Odland, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 950 East Bogard, Suite 234, Wasilla, AK 99654 Phone: 907-373-0850 Fax: 907-373-0117 |